Named on one round in the feed.
Since 2026-11-16
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Galvanize Therapeutics Galvanize Therapeutics designs pulsed electric field energy devices for surgical ablation of soft tissue, targeting healthcare providers and hospitals. | Series D Verified against 4 of 16 sources | $130M | 2026-11-16 | [ PART ] |